Apo­tex is­sues re­call of eye treat­ment over cracked bot­tle caps

Gener­ics man­u­fac­tur­er Apo­tex is vol­un­tar­i­ly pulling six lots of its bri­moni­dine tar­trate oph­thalmic so­lu­tion off the shelves af­ter cracks were re­port­ed on some bot­tle caps.

Bro­ken caps can im­pact the steril­i­ty of the prod­uct, and even lead to a po­ten­tial ad­verse event, the com­pa­ny said. The drug is used to re­duce in­traoc­u­lar pres­sure for pa­tients with open-an­gle glau­co­ma or oc­u­lar hy­per­ten­sion, and af­fect­ed batch­es were dis­trib­uted across the US be­tween April 5 of last year and Feb. 22, 2023.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.